The safety margin sits approximately 300-fold above therapeutic doses, making GHK-Cu one of the most well-tolerated peptides available for research purposes
It consists of only four atoms: a carbon atom with three hydrogen atoms
Another point I find notable is that iCare does not overcomplicate its business model with services it does not want to offer
Nanotechnology-based BBB crossing has been successfully demonstrated in preclinical animal studies of different neurological disorders such as Alzheimer's disease (260), brain cancer (261), and even stroke (262)
NAD(+) intermediates: the biology and therapeutic potential of NMN and NR
[9] Using retatrutide outside of an approved, ethics-committee-reviewed clinical trial carries significant risks, as research-grade peptides are not subject to the same manufacturing standards, purity controls, or safety oversight as licensed medicines